CD8A and pancreatic neoplasm: Additionally, N6-methyladenosine (m6A) modification is positively correlated with the number of CD8+ T cells in the immune microenvironment of pancreatic cancer, suggesting that m6A modification may play an important role in promoting the aggregation and activation of CD8+ T cells.